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Background: In leishmaniasis caused by Leishmania infantum, the dog acts as the main reservoir for the disease.
Non-invasive sampling for Leishmania detection is pivotal for rapid and affordable diagnosis. Recently, the use of
conjunctival swab (CS) has been evaluated as a non-invasive sampling technique for quantitative real-time PCR
(qPCR). However, few investigations have been made on the applicability of CS qPCR in particular cases such as
dogs with borderline IFAT titres, suspected disease relapse with comorbidity and therapy monitoring. The aims of
this study were i) to confirm the efficacy of CS, comparing these samples to buffy coat (BC) samples, as effective
non-invasive samples for Leishmania quantitative detection by qPCR and ii) to verify the usefulness of qPCR compared to
conventional laboratory and clinical parameters to assist in therapeutic decision making regarding dogs with complex
clinical cases.
Methods: Eighty dogs were divided into 4 groups based on their IFAT titres and clinical histories. Two qPCR assays were
performed both on CS raw lysates and on purified DNA from BC samples. The assays were then compared. Z tests for
difference of proportion, with Bonferroni correction, were carried out to evaluate the qPCR results. Logistic regression
with backward stepwise elimination was performed to detect the subset of haematochemical variables significantly
associated with PCR positivity.
Results: The qPCR performed on CS samples showed better sensitivity (87%) and specificity (96%) than assays carried
out using BC samples, regardless of the primers used. The haematochemical parameters haemoglobin and globulins
were found to be significantly associated with qPCR positivity. Pearson correlations between Leishmania kDNA load in CS
and body condition scores or IFAT titres were calculated in dogs with new leishmaniasis diagnoses. The Leishmania
kDNA load in CS correlated moderately with IFAT titres (R = 0.59) but a very weak correlation (R = 0.37) with body
condition score (BCS) was found.
Conclusions: The applicability of CS for Leishmania detection in dogs was confirmed, revealing the usefulness of raw
lysates for quantitative purposes. Moreover, the qPCR was found to be particularly useful in cases lacking a clear clinical
diagnosis, where the haematochemical values cannot be predictive.
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Leishmaniasis is a parasitosis caused by at least 15 Leish-
mania species. The parasite, primarily transmitted by
phlebotomine sand flies, cause 0.2–0.4 million cases of
visceral leishmaniasis (VL) and 0.7–1.2 million cases of
cutaneous leishmaniasis (CL) per year. Currently, 12 mil-
lion people are affected by the disease in 98 countries [1].
Specifically, Leishmania infantum is the aetiological
agent of zoonotic leishmaniasis, which is endemic in the
Mediterranean Basin, Central America, South America
and parts of Asia [2]. The dog is highly susceptible to L.
infantum infection and is the main reservoir for this
parasite. In light of this fact, the canine leishmaniasis
(CanL) is acknowledged as a very important problem in
veterinary medicine [3,4] and human epidemiology, also
because many infected dogs are asymptomatic [5,6]. Al-
though many diagnostic systems have been developed,
the gold standard in the diagnosis of CanL is still open
to debate [7,8]. The indirect fluorescence antibody test
(IFAT) is considered as a reference method by the World
Organization for Animal Health (OIE-Office International
des Epizooties) among serological techniques [9]. Never-
theless, these techniques are not always reliable in the pe-
riods of prepatent infection, remission stages and in the
latent forms of the disease like in “cryptic leishmaniasis”
[10]. Moreover, particularly in Central and South America,
IFAT can have cross-reactivity with other pathogens like
Trypanosoma cruzi, Trypanosoma caninum, Leishmania
braziliensis, and Ehrlichia canis [11]. In addition, in areas
where the pathogen is endemic, uncertain IFAT titres ran-
ging from 1:40 to 1:80 (below the positivity threshold:
titre ≥ 1:160), are found in a significant number of animals.
These titres, defined also as “borderline titres” [12], may
be difficult to interpret by veterinary practitioners. In this
context, molecular techniques can improve the diagnosis
of leishmaniasis. In particular, qualitative and quantitative
PCR (qPCR) may play an important role in parasite detec-
tion [13] and therapy monitoring [14,15], in both human
and in veterinary medicine. In molecular methods, the
constant region of Leishmania minicircles has been widely
used as a specific target because of its very high number
of target sequences [16-19]. Moreover, splenic aspirates
and bone marrow are currently considered the clinical
samples which yield the best sensitivity results [20,21].
Unfortunately, these samples are obtained with invasive
procedures and usually require a general anaesthesia. The
use of DNA purified from conjunctival swabs (CS) for
PCR-based diagnosis of CanL was introduced in order to
reduce the need for invasive procedures [22,23]. Moreover,
Peña et al. [24] characterized the diffusion of the Leish-
mania parasite in different ocular tissues of infected dogs.
More recently, Lombardo et al. [25] verified that CS have
a sensitivity similar to that of lymph node samples, while
de Almeida et al. [26] showed comparable PCR sensitivityin CS and bone marrow. Furthermore, the usefulness of
CS PCR as diagnostic tool has also been confirmed in
non-endemic areas [27]. Contextually, the sensitivity and
utility of whole blood or buffy coat (BC) in veterinary
medicine are still much disputed. In fact, PCR-based
Leishmania detection in CanL using whole blood or buffy
coat is not without difficulties [18]. It showed results vari-
ability [23,26-29], and is considered of little diagnostic
value [30]. On the other hand, reliable therapy monitoring
requires parasite quantification that may be difficult to
achieve with the CS samples. In fact, CS analysis can be af-
fected by variations in the amount of biological material
sampled, which can vary among different samples from
the same patient (for example pre-treatment and treat-
ment phases). The usefulness of CS has been evaluated in
the early diagnosis of leishmaniasis, but few works investi-
gated their utility in the therapy monitoring [13]. More-
over, this approach has not been thoroughly investigated
as a possible tool that could help guide treatment deci-
sions in borderline cases, when there is suspicion of dis-
ease relapse or comorbidity. In the present investigation,
we confirmed the usefulness of qPCR as a quantitative
diagnostic tool using CS raw lysate samples as a source of
DNA, particularly in cases with borderline IFAT titres,
suspected disease relapse or the presence of comorbidity.
Moreover, we identified the haematochemical parameters
significantly associated with qPCR positive results.
Methods
Ethical statement
The study was approved by the Ethical Committee for
Animal Experiments of the University of Urbino (CESA)
on July 31st 2012. The study’s title was “Diagnosi biomo-
lecolare della leishmaniosi attraverso l’uso di campioni
clinici non invasivi e loro utilizzo per il monitoraggio
terapeutico” (Prot. CESA 2/2012).
Dogs
The study was carried out in the Marches region (Central
Italy), where L. infantum is present as a parasite. A total of
80 dogs were enrolled (45 males, 35 females). The dogs
either lived in kennels or with their owners. Two of the
dogs were of unknown breed, 24 were mongrels and 54
were pure breeds. The median age of 51 dogs was 6 years
(range: 2 months −15 years); the remaining 29 dogs were
adults of unknown age. The dogs were examined by veter-
inary practitioners for the presence of signs attributable to
Leishmania infection and scored for clinical signs from 0
to 14. A single point was attributed for each of the follow-
ing 14 clinical signs: alopecia, dermatitis, skin ulceration,
ocular lesions, dysorexia, weight loss, asthenia, vomiting
and/or diarrhoea, epistaxis, hyperthermia, lymphadenop-
athy, lameness, onychogryposis and other (eventually spe-
cified). Dogs with a body condition score (BCS) of 0 were
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symptomatic; those with a score of 3–6, oligosymptomatic;
and animals with a score of 7–14, polisymptomatic.
In light of the IFAT results (see below) and conside-
ring their clinical history, the dogs were divided into 4
groups: A) IFAT negative dogs (n = 24), composed of
healthy dogs (n = 14 with a clinical score of 0) and also
symptomatic dogs suspected of having leishmaniasis by
veterinary practitioners (n = 10 with clinical score 1–8);
B) suspected for leishmaniasis (IFAT from 1:40 to 1:80;
n = 17); C) dogs monitored after successful therapy
(IFAT ≥ 1:160 at the time of first diagnosis; n = 16), com-
posed of dogs that were diagnosed with leishmaniasis
before the beginning of this study and brought to the
veterinary clinic for a re-evaluation, in some cases be-
cause of the reappearance of symptoms (clinical score from
0 to 6); D) newly positive dogs (IFAT ≥ 1:160; n = 23). A
further subgroup (group E) comprised dogs monitored
during therapy (IFAT ≥ 1:160; n = 4). This group included
dogs with qPCR results available both at the time of diag-
nosis and during therapy (dog 57, also included in group
C; dogs 67, 68, 72, also included in group D).
Canine samples
Canine peripheral blood (drawn for routine clinical tests)
and conjunctival swabs (CS) were provided by the “Santa
Teresa” Veterinary Clinic (Fano, Italy). Serum for bio-
chemical assays and protein electrophoresis was obtained
after the centrifugation of peripheral blood collected in a
tube with serum-granules clotting activator at 1,900 × g
for 5 min. The separated serum was stored at −20°C until
it was analyzed. The whole blood (1 ml) for haemato-
logical assays was collected in tubes with EDTA and im-
mediately analyzed. The buffy coat samples (100 to
320 μl) were obtained after centrifugation of residual per-
ipheral blood at 210 × g for 10 min. Conjunctival swabs
were collected from the right and left conjunctivas using
sterile cotton swabs. The swabs were rubbed with a rota-
tional movement back and forth three times in the lower
conjunctival sac.
IFAT was performed on serum samples with an in-
house assay validated and provided by the Institute of
Experimental Preventive Veterinary Medicine (Istituto
Zooprofilattico Sperimentale) of Sicily (IZS) [30]. In ac-
cordance with Gradoni et al. [12], IFAT titres below 1:40
were considered negative, those from 1:40 to 1:80 were
defined as borderline and those ≥1:160 were considered
positive.
Clinical chemistry and haematological assays
Protein and albumin were quantified using an automated
spectrophotometer (Pronto Evolution, BPC BioSed, Roma,
Italy) and Giesse Diagnostics commercial kits (Giesse
Diagnostics srl, Rome, Italy), based on the biuret andbromocresol green methods, respectively. Protein frac-
tions were measured in 25 μl of serum by electrophoresis
on cellulose acetate membranes (Auto Phor 400, Bio
Group Medical System s.r.l., Talamello, Italy) and buffer
(pH 8.8; Auto Phor 400, Bio Group Medical System s.r.l.,
Talamello, Italy) in a semi-automated electrophoresis
analyzer (AdaLya 24, Seleo Engineering s.r.l., Orta di
Atella, Italy) according to the manufacturer’s instructions.
The haematological assays where performed using the
coulter system Genius Vet haematology analyzer (Seac srl
Radim Group, Calenzano, Italy).DNA extraction
The DNA was extracted from buffy coat and conjunc-
tival samples as previously described [31]. Briefly, the
DNA from buffy coat samples was extracted using the
DNeasy Blood & Tissue kit (Qiagen), while the DNA
from swabs was extracted by incubation for 2 h at 56°C in
200 μl lysis buffer (10 mM Tris–HCl pH 8.3, 50 mM KCl,
0.5% Nonidet P40, 0.5% Tween 20, 0.1 mg/ml proteinase
K). After swab elimination, the samples were incubated
for 10 min at 95°C and centrifuged at 14,000 × g for
10 min. Supernatants (raw lysates) were used directly as
templates in PCR reactions.Quantitative PCR (qPCR) assays
Two qPCR assays were performed using two different
primer pairs (MaryF-MaryR and MLF-MLR primers for
qPCR1 and qPCR2, respectively) as previously reported
[31]. Both primer pairs targeted the constant region of L.
infantum kDNA minicircle. The standard curve was
established using serial dilutions of Chelex-purified L.
(L.) infantum MHOM/TN/80/IPT1 DNA, ranging from
100 to 0.001 parasites equivalent.
In CS samples, for quantitative purposes and to ex-
clude false negative results due to low DNA extraction
efficiency and/or the presence of PCR inhibitors, the ca-
nine beta-2-microglobulin (B2M) gene was used as a ref-
erence (qPCR3). In fact, quantification of the B2M gene
was used to estimate the number of cells withdrawn in
CS samples and consequently to normalize the Leish-
mania parasites to the number of canine cells. The
primers B2Mcanis_F (5′-GTCCCACAGATCCCCCAAA
G-3′) and B2Mcanis_R (5′- CTGGTGGATGGAACCC
TGAC-3′) were used under the same conditions of
qPCR1 and qPCR2. The B2M standard curve was con-
structed with serial dilutions of the B2M PCR product
quantified using Qubit fluorometer (Life Technologies).
In addition to the parasite quantification, a ΔCt value
between Leishmania and B2M amplification curves (ΔCt
Leish-B2M) was evaluated as an additional parameter to
monitor parasite load changes in the same animal during
the course of the illness or treatment. In fact, increases
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or increases in parasite loads, respectively.
Statistical analysis
Descriptive statistics were performed with quantitative
variables; PCR quantifications were log10 transformed in
order to meet assumption of normal distribution. Ana-
lysis of variance (ANOVA) was used to test the associations
between dog groups, clinical chemistry and haematological
values. Z tests for proportions were performed in order to
compare specificity and sensitivity values. The area under
the receiver operating characteristic curve (AUC) allows an
evaluation of the overall performance of a test or classifica-
tion, i.e. its diagnostic accuracy; reported effect size inter-
vals for AUC are: small effect sizes (0.528–0.556); medium
effect sizes (0.584–0.638); large effect sizes (0.714–0.760);
very large effect sizes (above 0.760) [32]. A good description
of classification accuracy can be obtained by plotting an
ROC (receiver operating characteristic) curve. The curve
shows the probability of detecting true positives (sensitivity)
and false positives (1-specificity) for an entire range of pos-
sible cut-points. Logistic regression with backward stepwise
elimination were performed to detect the subset of first-line
haematochemical variables significantly associated with
PCR positivity. Every predictive variable (platelets, globu-
lins, ratio albumin/globulins, white blood cells, red blood
cells, haemoglobin, albumin) was dichotomized in 0 = value
in physiological range and 1 = value out of physiological
range. The Nagelkerke R square was reported as fitting
index. The odds ratio and relative 95% confidence interval
were reported for each predictive variable. All data were
coded and analyzed using the Statistical Package for Social
Science (SPSS) for Windows (Chicago, IL 60606, USA), ver-
sion 13, or Excel 2003 (Microsoft_Office).
Results
IFAT, clinical chemistry and haematological parameters
Clinical parameters at the time of sampling for molecu-
lar assays for all the dog groups in our study are shown
in Table 1. Clinical parameters values of all animals are
supplied as supplementary materials (Additional file 1:
Table S1). Serum electrophoresis was available for 47
dogs only (Additional file 2: Table S2). Such parameters
did not provide significant information to decide
whether to include dogs from groups B and C in the
group of infected dogs requiring anti-Leishmania ther-
apy (ANOVA test; p > 0.05). Therefore, the qPCR assays
were used to detect and quantify the Leishmania para-
sites in CS and BC samples.
qPCR from conjunctival swabs (CS qPCR) and from buffy
coat (BC qPCR)
The presence of Leishmania parasites was assessed in
the dogs assigned to all groups by qPCR both fromconjunctival swabs (CS qPCR) and buffy coat (BC
qPCR). The qPCRs were initially performed with MaryF-
MaryR primers (qPCR1); the positive results were subse-
quently confirmed using MLF-MLR primers (qPCR2). The
amount of CS raw lysates to be used as a template in qPCR
without any inhibitory effects was established as 1 μl per
25 μl reaction tube, maintaining the previously reported
sensitivity (1×10−3 par/reaction tube) [31] (Figure 1). This
raw lysate volume was used for all samples.
To allow normalization of the CS parasite load and to
further exclude false negative results, all qPCR positive
CS samples and part (34.5%) of the qPCR negative CS
samples were tested for B2M amplification. In order to
quantify the B2M copy number, a calibration curve was
constructed using serial dilution of a purified PCR prod-
uct (Additional file 3: Figure S1). On the whole, the
B2M Ct average in CS samples was 23.26 ± 3.26 (n = 97
samples tested in duplicate). Assuming that B2M gene is
present in two copies per diploid cell, the average Ct
value corresponded to 49,950 cells per CS total raw lys-
ate. This cell content was extremely variable from sam-
ple to sample, ranging from a minimum of 130 to a
maximum of 2.34 × 106 cells, with a median value of
75,590 cells, hence the need for a reference gene for
normalization. The final CS qPCR results were
expressed as the number of parasites normalized to
50,000 canine cells. The overall results of qPCR assays
are reported in Table 2. Briefly, in group A 5 dogs were
BC-positive and one of them was also CS-positive; in
group B, one dog was BC-positive and 2 were CS-
positive; in group C, 6 were BC-positive and 3 CS-
positive; in group D, 20 and 14 dogs were found positive
in CS and BC samples, respectively. The differences ob-
served in the parasite quantifications between the two
qPCR assays probably reflected the variability of minicir-
cle subpopulations in the endemic Leishmania strains,
compared to the reference strain MHOM/TN/80/IPT1
used to construct the standard curve [31].
Sensitivity and specificity results of all qPCR assays
were compared and were significantly higher in CS
qPCR than in BC qPCR, regardless of the primers that
were used (Figure 2). No significant differences in terms
of sensitivity and specificity results were observed be-
tween qPCR1 and qPCR2 in CS or BC samples (Z tests
for difference of proportion, with Bonferroni correction).
Since qPCR1 and qPCR2 results were comparable, only
qPCR1 results were taken into consideration for subse-
quent statistical analyses.
Pearson correlations between the quantitative load of
Leishmania kDNA in CS and BCS or IFAT titres were
calculated in group D. The CS qPCR1 results correlated
moderately with IFAT titres (R = 0.59), but the correl-
ation with BCS was very weak (R = 0.37), according to
previous literature data [27].
Table 1 IFAT, body condition score (BCS), clinical chemistry and haematological mean values for all groups
Group (Dog ID) IFAT BCS Prot (g/dl) Alb (g/dl) Glob (g/dl) Ratio Alb/Glob WBC (103/μl) RBC (106/μl) Hgb (g/dl) Hct (%) Plt (103/μl)
A(1–24) mean ± s.e. - 1.04 ± 0.37 6.49 ± 0.23 3.43 ± 0.14 3.05 ± 0.09 1.17 ± 0.14 15.34 ± 2.91 5.82 ± 0.27 15.28 ± 0.72 41.14 ± 1.81 292.83 ± 19.98
min <1/40 0 5.67 2.64 2.09 0.71 8.6 2.4 6.3 19.2 198
max <1/40 8 7.96 4.0 4.46 1.77 62.0 7.87 20.3 52.9 470
B(25–41) mean ± s.e. - 1.82 ± 0.52 6.86 ± 0.26 3.02 ± 0.06 3.85 ± 0.24 0.81 ± 0.05 11.95 ± 1.39 5.48 ± 0.22 14.22 ± 0.56 38.32 ± 1.30 347.55 ± 26.43
min 1:40 0 5.86 2.8 2.96 0.55 6.2 4.30 11.1 31.1 185
max 1:80 8 8.16 3.5 5.26 1.06 23.0 6.90 18.3 45.6 470
C(42–57) mean ± s.e. - 1.69 ± 0.49 6.63 ± 0.20 3.00 ± 0.13 3.63 ± 0.17 0.84 ± 0.06 9.88 ± 2.30 5.29 ± 0.62 14.19 ± 1.69 37.73 ± 4.30 258.08 ± 40.30
min 1:80 0 5.83 1.9 2.53 0.45 4.2 0.92 2.7 7.4 106
max 1:1280 6 8.35 3.9 5.15 1.30 28.7 7.14 19.4 50.7 523
D(58–80) mean ± s.e. - 3.61 ± 0.58 8.18 ± 0.33 2.48 ± 0.14 5.71 ± 0.39 0.54 ± 0.09 10.89 ± 1.06 5.02 ± 0.31 12.09 ± 0.73 34.32 ± 2.13 207.63 ± 22.58
min 1:160 0 5.60 0.96 1.90 0.13 3.2 1.94 5.5 15.0 47
max 1:10240 11 10.84 3.7 8.52 1.95 19.0 6.87 17.9 48.7 383
















Figure 1 qPCR1 sensitivity without (A) or with (B) raw CS lysate. Serial dilutions of MHOM/TN/80/IPT1 L. infantum DNA (ranging from 1 to
0.001 parasite equivalent) were amplified in triplicate (1 μl in a total of 25 μl reaction mixture) (panel A). To evaluate the eventual inhibitory
effects, 1 μl of raw lysate was spiked in the PCR tubes containing the dilutions of MHOM/TN/80/IPT1 L. infantum DNA described above
(panel B).
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parameters as first line detection of Leishmania infection
The clinical parameters shown in Table 1 were re-
evaluated considering the CS qPCR-positive and negative
dogs (n = 27 and n = 45, respectively), to identify the pa-
rameters related to the presence of Leishmania DNA and
to evaluate the usage of these parameters as a first line
diagnostic approach in suspected cases with borderline
IFAT titres 1:40–1:80 (i.e. group B), and previously in-
fected dogs (i.e. group C).
Logistic regression with backward stepwise elimination
showed that only globulins (O.R. = 6.00; C.I. = 1.51-23.87)
and haemoglobin (O.R = 6.01; C.I. = 1.26-28.56) were sig-
nificantly associated with group membership. Nagelkerke
R square was 0.39, showing a modest but significant good-
ness of fit. Logistic regression specificity and sensitivity
values were 0.704 and 0.739, respectively. If both globulins
and haemoglobin parameters are above and below the
normality range, respectively, the probability to belong to
the infected group is 80%, whereas when both clinical pa-
rameters are in normality range, the probability to belong
to the infected group is 20%.Use of CS qPCR for therapy monitoring
The efficiency of the qPCR assays used in this study
were calculated to evaluate the possibility of making a
direct comparison between the Ct values of Leishmania
kDNA and the canine B2M gene. The qPCR efficiencies
were calculated using serial dilutions of two CS lysates
(from dogs 21, 38) spiked with known amounts of L.
infantum MHOM/TN/80/IPT1 DNA. The ΔCt between
B2M (qPCR3) and Leishmania kDNA (qPCR1 and qPCR2)
were plotted against dilutions of CS lysates spiked with L.
infantum DNA. The slope of the trend lines was < 0.1, indi-
cating comparable PCR efficiencies [33] (Additional file 4:
Figure S2). Hence, we concluded that a ΔCt value between
Leishmania kDNA and canine B2M gene could be used to
evaluate the trend of therapy or illness progression in the
same animal.
Four infected dogs (57, 67, 68, 72) diagnosed with
leishmaniasis, entered a therapeutic protocol and were
monitored for parasite load in CS samples during ther-
apy. Three dogs resulted qPCR negative in left and right
CS samples after initiation of therapy; one dog (number
67) resulted qPCR negative in the left CS, and presented
Table 2 Leishmania parasite quantification in buffy coat (BC) and conjunctival swab (CS) samples, by qPCR1 (normal
text) and by qPCR2 (bold text)






A < 1:40 1 0.01 0.00 0.00
n.a. n.a. n.a.
2, 5 0.00 n.a. n.a.
n.a. n.a. n.a.
4 22.27 97.84 9.65
10.40 23.16 0.00
6 0.04 n.a. n.a.
n.a. n.a. n.a.
7 0.03 0.00 0.00
n.a. n.a. n.a.
12 4.26 0.00 0.00
6.45 n.a. n.a.
3, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 0.00 0.00 0.00
n.a. n.a. n.a.
B 1:40 – 1:80 25, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 41 0.00 0.00 0.00
n.a. n.a. n.a.
26 0.07 0.00 0.00
n.a. n.a. n.a.
27 n.a. 0.05 0.00
n.a. 0.15 0.00
39 0.00 0.00 n.a.
n.a. n.a. n.a.
40 0.00 0.01 0.06
n.a. 0.06 0.89
C ≥ 1:160 42 0.00 0.08 0.00
n.a. n.a. n.a.
43 0.7 n.a. n.a.
n.a. n.a. n.a.
44 1.16 0.00 0.00
0.00 n.a. n.a.
45 0.10 86.50 3.55
0.14 688.97 36.35
46 0.43 0.00 0.00
4.45 n.a. n.a.
47 0.00 0.00 0.02
n.a. n.a. n.a.
48 0.21 0.00 0.00
0.00 n.a. n.a.
49, 51, 52, 53, 54, 55, 56 0.00 0.00 0.00
n.a. n.a. n.a.
50 0.07 0.00 0.00
n.a. 0.00 0.00
57 0.00 0.00 1.83
Ceccarelli et al. Parasites & Vectors 2014, 7:460 Page 7 of 12
http://www.parasitesandvectors.com/content/7/1/460
Table 2 Leishmania parasite quantification in buffy coat (BC) and conjunctival swab (CS) samples, by qPCR1 (normal
text) and by qPCR2 (bold text) (Continued)
n.a. n.a 3.66
D ≥ 1:160 58 0.52 0.00 0.00
3.40 0.00 0.00
59 1.49 n.a. n.a.
5.00 n.a. n.a.
60 2.83 2.37 3.97
19.20 7.43 15.90
61 1.43 999.28 184.77
1.28 1625.05 372.43
62 8.00 0.46 8.00
0.77 n.a. 63.90
63 0.00 0.98 0.70
n.a. 3.01 n.a.
64 0.00 0.00 2.10
n.a. n.a. 28.82
65 1.72 1659.79 808.35
11.93 4690.98 3147.88
66 0.00 88.03 33.44
0.00 29.87 71.67
67 0.35 9.36 9.80
0.27 4.25 3.67
68 0.00 4.11 70.96
n.a. 7.59 57.75
69 0.00 189.23 16.42
n.a. 129.50 30.96
70 0.12 3.21 n.a.
0.18 8.38 n.a.
71 0.00 32.60 19.38
n.a. 77.64 39.74
72 0.00 1.13 49.54
0.00 6.72 227.29
73 0.88 33.35 184.18
4.94 139.98 683.95
74 0.56 13.08 11.73
4.68 24.74 9.50
75 264.28 85.94 183.85
1315.97 717.96 1969.04
76 0.34 5.89 12.22
1.52 50.43 56.03
77 2.96 44.31 50.67
10.87 278.25 282.91
78 n.a. 0.00 0.00
n.a. n.a. n.a.
79 19.38 616.82 74.82
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Table 2 Leishmania parasite quantification in buffy coat (BC) and conjunctival swab (CS) samples, by qPCR1 (normal
text) and by qPCR2 (bold text) (Continued)
n.a. 2609.35 222.93
80 0.00 0.26 0.44
n.a. 0.85 0.35
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sample the decrease in parasite load was verifiable by
the increase in the ΔCt Leish-B2M value (Table 3).
Discussion
The development of non-invasive sampling techniques is
a worthy goal in human and veterinary medicine. In
addition, in veterinary medicine, even more than in hu-
man medicine, there is a need for rapid sampling, limiting
the use of patient sedation. Conjunctival swabs appear to
be a very useful non-invasive sampling method although
the technique may have drawbacks regarding sensitivity
[34] and quantification due to variability in the amount of
biological material collected. To get around the variability
issue the CS qPCR results can be normalized to theFigure 2 Sensitivity and specificity analyses of qPCR assays. A) ROC cu
samples. B) Sensitivity, specificity and area under the curve (AUC) related tonumber of canine cells by parallel quantification of a sin-
gle copy canine gene (e.g. β-actin) [26]. Several studies
have focused on the usefulness of CS PCR in the initial
diagnosis of CanL but little research has been done on its
applicability in particular clinical cases.
The present study assessed the diagnostic value of CS
qPCR in dogs with borderline IFAT titres, suspected dis-
ease relapse or the presence of comorbidity, comparing
the CS qPCR results with BC qPCR and haematochemical
analyses. The use of BC samples to detect Leishmania in
dogs is a much debated issue [35-37]. Our study con-
firmed that BC qPCR is not as accurate as CS qPCR as a
tool to rule out suspected leishmaniasis infection. How-
ever, BC qPCR could be useful for CanL diagnosis con-
firmation, and/or for blood donor dog screening, as werves related to qPCR1 and qPCR2 performed in BC samples and CS
qPCR1 and qPCR2.
Table 3 CS qPCR1 application for therapy monitoring




Left ΔCt Right ΔCt Therapy protocol
57 0 0.00 1.83 – 4.51 Glucantime doxycycline
17 0.00 0.00 – –
67 0 9.36 9.80 −0.25 −0.28 Miltefosine
30 0.00 1.87 – 2.46
68 0 4.11 70.96 1.05 −3.15 Glucantime allopurinol
56 0.00 0.00 – –
72 0 1.13 49.54 3.67 −1.77 Glucantime allopurinol
49 0.00 0.00 – –
*day 0 corresponds to initiation of therapy.
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http://www.parasitesandvectors.com/content/7/1/460observed in the cases of dogs 4 and 12 in this investiga-
tion. At the time of screening, these dogs were IFAT nega-
tive and without clinical symptoms, but both resulted BC
qPCR positive (with a middle-high load). Only dog 4 was
also CS qPCR positive. Ten months after the biomolecular
positivity, the IFAT was borderline with a titre of 1:40 but
still no symptomatology. This highlights the importance
of biomolecular analysis in blood donor screening because
these dogs were suspended from donor program only after
testing positive with the BC qPCR. In fact, Leishmania
DNA positivity without symptomatology may reflect sea-
sonal contact with the infected vector and does not neces-
sarily involve the appearance of specific symptoms also in
the presence of borderline IFAT titres [10,38]. BC qPCR
positivity with no clinical signs also occurs in humans.
Specifically, the transition from biomolecular positive to
negative results has been observed in pediatric patients
without symptomatology [35].
In order to obtain quantitative data from CS samples,
the parasite load was normalized using the B2M gene and
the results were expressed per 50,000 canine cells. The
normalization can overcome the problem due to the in-
trinsic variability of the swab sampling and would be help-
ful to compare data from different laboratories also
because of the non-standardized way of collecting con-
junctive cells using swabs. This procedure allowed us to
quantify the CS parasite load and to monitor the same
animal during therapy; however, it increased the cost of
analysis and required more time. This disadvantage was
partially reduced by using SYBR Green and CS raw lysate
as the source of the DNA template. In fact, the use of CS
raw lysate, instead of DNA extracted with the phenol-
chloroform method [23,26,39] or with commercial kits
[25,27], enabled us to obtain good sensitivity (1×10−3 par/
reaction tube), at a low cost and without inhibitory effects
when 1 μl per reaction tube was used. We found a CS-
qPCR sensitivity and specificity of 87% and 96%,
respectively, confirming and improving on the results
obtained by Gramiccia et al. [29]. These data were alsoin agreement with other previous investigations [23,26] al-
though those authors used the phenol-chloroform method.
Interestingly, among the clinical and haematological pa-
rameters considered, those most associated with qPCR
positive results were globulins and haemoglobin. This find-
ing seems to suggest that these parameters in particular
should be considered during first-line laboratory tests in
the case of suspected CanL or evaluation of disease relapse.
However, even considering these parameters, relevant un-
certainty remained, supporting the need of a wider use of
qPCR.
The present study also investigated the use of CS
qPCR in borderline and disease relapse cases with com-
plex diagnosis, including comorbidity. In group B (bor-
derline cases) only 2 dogs (27 and 40) out of 17 tested
positive with CS qPCR. Dog 27 showed a very low para-
site load in the left CS (0.05 par/50,000 cells). The BCS
was 1, IFAT titre was 1:40 and serum electrophoresis
and biochemical analysis were normal; however the hae-
mochrome showed a moderate anaemia compatible with
leishmaniasis. Prina et al. [40] demonstrated that Leish-
mania DNA is rapidly degraded following parasite death;
hence, its identification in conjunctival tissue could be
indicative of recent extraepidermical dissemination that,
in presence of clinical signs or, as in this case, haemato-
logical signs, could require treatment or close monitoring.
Another complicated case study, in terms of therapeutic
decisions, was dog 40 because of the presence of comor-
bidity. This dog was in therapy for hypothyroidism when
Leishmania was detected. Subsequently, Dirofilaria spp.,
Trichuris spp. and Toxocara spp. were also diagnosed by
optical microscopy. There were no significant alterations
in biochemical and haematological parameters but the
BCS was 8. Regarding the qPCR positive results, although
indicating low parasite load, the veterinary practitioner
started the animal on a canine Leishmania therapy with
allopurinol alone and specific therapy for the other para-
sitosis mentioned above. An evident improvement in
symptoms was reported four months later.
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http://www.parasitesandvectors.com/content/7/1/460Furthermore, eight dogs (42, 43, 44, 45, 46, 48, 50, 57)
out of 16 in group C (monitored after therapy) tested
positive in at least one of the BC and CS samples ana-
lyzed. It is noteworthy that only dog 42 had important
alterations in its biochemical values; 6 out of 6 with avail-
able data had alterations in their electrophoretic patterns
(Additional file 2: Table S2) and 4 out of 7 with available
data had anemia or thrombocytopenia (the hemogram of
dog 50 was not available). These data suggest that qPCR is
a very important and specific tool in the monitoring of
disease relapse. In fact, various comorbidities were
found in dogs 42, 43, 45 and 46. These comorbidities
potentially interfered with the electrophoresis panel,
but the positive qPCR confirmed the suspicion of a
leishmaniasis relapse.
Many authors have suggested the use of biomolecular
approaches in therapy monitoring, observing that a re-
sidual parasite load is normally found in samples from
lymph-nodes or bone marrow after therapeutic protocols
[15]. This could complicate the assessment of thera-
peutic response in some cases. Hence, we also investi-
gated the potential role of CS in therapy monitoring. A
parasite load = 0 in dogs under the treatment (group E)
was found in 3 out of 4 dogs tested during their therapy,
while the dog 67 presented a parasite reduction in the
right CS, which was reflected by the increase in the ΔCt
Leish-B2M value. Despite the low number of animals,
this could furnish a proof of concept that this relative
approach could be used, avoiding parasite load absolute
quantification.Conclusions
In conclusion, this study has shown the practical appli-
cation of a qPCR assay in canine leishmaniasis diagnosis,
which can be used together with conventional assays,
providing valuable additional information for veterinary
therapeutic choices. Moreover, our investigation also
suggests that CS qPCR is not only useful for first initial
diagnosis but also provides useful information for thera-
peutic decisions in borderline cases and in disease re-
lapse re-evaluation. Furthermore, the data showed that,
in the conventional laboratory analyses that were consid-
ered, the values of globulins and haemoglobin were
more strongly associated with CS qPCR positivity.
Lastly, the equivalence of qPCR1 and qPCR2 was veri-
fied, and a different method of therapy monitoring, inde-
pendent of parasite load quantification, was introduced. In
fact, calculating the ΔCt Leish-B2M, it was possible to ob-
tain a value that should increase during an effective ther-
apy or diminish/remain stable in the case of therapy
failure or disease relapse. This approach could get around
the problem of exact parasite load quantification (based
on standard reference strains) and relative normalization.On the whole, the CS qPCR results obtained in dogs
suggest more extensive investigation of the use of this
kind of samples in human cases also.
Additional files
Additional file 1: Table S1. Clinical parameters for all animals.
Additional file 2: Table S2. Serum electrophoresis results.
Additional file 3: Figure S1. B2M calibration curve. The curve was
obtained by 10-fold serial dilution of purified PCR product ranging from
19.4 to 19.4 × 107 molecules of B2M PCR product.
Additional file 4: Figure S2. Relative efficiency plot of B2M (qPCR3) and
Leishmania kDNA amplified with qPCR1 (A) and qPCR2 (B). ΔCt values
(Ct Leishmania kDNA - Ct B2M) were plotted against log of dilutions of CS
lysate samples spiked with L. infantum DNA (equivalent to 1 × 103 par/μl).
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